Pancreatic Cancer Research

ResearcherNankai UniversityActive in the last 2 years

Tianyang Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5905-8317; OpenAlex author ID A5101808016. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 3

  1. Identification of a Small Molecule as Potential Hypoxia-Selective Agents by Reducing Membrane Localization of ENO1 in Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.jmedchem.5c03550↗
  2. Disruption of the sorcin‒PAX5 protein‒protein interaction induces ferroptosis by promoting the FBXL12-mediated ubiquitination of ALDH1A1 in pancreatic cancer. Co-author DOI 10.1186/s13045-025-01680-8↗
  3. Probe Synthesis Reveals Eukaryotic Translation Elongation Factor 1 Alpha 1 as the Anti-Pancreatic Cancer Target of BE-43547A2. Co-author DOI 10.1002/anie.202206953↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yahui Ding · 3 shared papers, 2022–2026 · strength 0.72
  2. Quan Zhang · 1 shared paper, 2026 · strength 0.29
  3. Yuehua Chen · 1 shared paper, 2026 · strength 0.29
  4. Quan Zhang · 1 shared paper, 2025 · strength 0.28
  5. Can Liu · 1 shared paper, 2022 · strength 0.15
  6. Yuanjun Sun · 1 shared paper, 2022 · strength 0.15
  7. Yue Chen · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.